Cytokine production and modulation: Comparison of patients with chronic fatigue syndrome and normal controls

References 

1. Archard LC, Bowles NE, Behan PO, Bell EJ, Doyle D. Postviral fatigue syndrome: persistence of enterovirus DNA in muscle and elevated creatine kinase. Journal of the Royal Society of Medicine. 1988;81:326–329
   • MEDLINE
2. Bennett AL, Chao CC, Hu S, Buchwald D, Fagioli LR, Schur PH, et al. Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. Journal of Clinical Immunology. 1997;17:160–166
   • MEDLINE
   • CrossRef
3. Borish L, Schmaling K, Diclementi J, Streib J, Negri J, Jones JF. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables. Journal of Allergy and Clinical Immunology. 1998;102:222–230
4. Bouchard C, Galinha A, Tartour E, Fridman WH, Sautes C. A transforming growth factor beta-like immunosuppressive factor in immunoglobulin G-binding factor. Journal of Experimental Medicine. 1995;182:1717–1726
5. Chao CC, Janoff EN, Hu SX, Thomas K, Gallagher M, Tsang M, et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokines. 1991;3:292–298
6. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. Journal of Experimental Medicine. 1993;178:1041–1048
7. Kekow J, Wachsman W, McCutchan JA, Gross WL, Zachariah M, Carson DA, et al. Transforming growth factor-beta and suppression of humoral immune responses in HIV infection. Journal of Clinical Investigation. 1991;87:1010–1016
8. Komaroff AL. Chronic fatigue syndromes: relationship to chronic viral infections. Journal of Virology Methods. 1988;21:3–10
9. Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Review of Infectious Diseases. 1991;13:S8–S11(Suppl.)
10. Levy JA. Viral studies of chronic fatigue syndrome. Clinical Infectious Diseases. 1994;18:S117–S120(Suppl.)
11. Lloyd AR, Wakefield D, Boughton CR, Dwyer JM. Immunological abnormalities in the chronic fatigue syndrome. Medical Journal of Australia. 1989;151:122–124
12. Lloyd AR, Hickie L, Wakefield D, Boughton C, Dwyer J. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. American Journal of Medicine. 1990;89:561–568
13. MacDonald KL, Osterholm MT, LeDell KH, White KE, Schenck CH, Chao CC, et al. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. American Journal of Medicine. 1996;100:548–554
14. Miike T, Tomoda A, Joudoi T, Iwatani N, Mabe H. Learning and memorization impairment in childhood chronic fatigue syndrome manifesting as school phobia in Japan. Brain Development. 2003;13:266–269
15. Moutschen M, Triffaux JM, Demonty J, Legros JJ, Lefebvre PJ. Pathogenic tracks in fatigue syndrome. Acta Clinica Belgica. 1994;49:274–289
    • MEDLINE
16. Peterson PK, Shepard J, Macres M, Schenck C, Crosson J, Rechtman D, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. American Journal of Medicine. 1990;89:554–560
17. Peterson PK, Sirr SA, Grammith FC, Schenck CH, Pheley AM, Hu S, et al. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clinical and Diagnostic Laboratory Immunology. 1994;1:222–226
    • MEDLINE
18. Yousef GE, Bell EJ, Mann GF, Murugesan V, Smith DG, McCartney RA, et al. Chronic enterovirus infection in patients with postviral fatigue syndrome. Lancet. 1988;1:146–150
    • MEDLINE
19. Yssel H, De Waal MR, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H, et al. IL-10 is produced by subsets of human CD4+T cell clones and peripheral blood T cells. Journal of Immunology. 1992;149:2378–2384